Share

March 2022 Healthcare Conference — Synthetic Biology Enabling Technologies Panel

This is an ideal forum for objective first-hand updates on both marketed and emerging products across the sector with more than 375 public and private companies across the entire health care spectrum. Cowen research analysts will host public companies in fireside chat sessions and corporate panel discussions to engage in enlightening discussion with management teams.
Join the Synthetic Biology Enabling Technologies Panel on March 7 at 10:30 am ET

Efficient and Rapid Discovery of Novel Temperature Sensitive Alleles with the Onyx ® Digital Genome Engineering Platform
Temperature sensitive (TS) alleles are mutations in essential genes that allow for growth at permissive temperatures and restrict or reduce...
Read More
Accelerating strain development process for CDMO and CRO companies
Manufacturing of proteins, mRNA or small molecules requires comprehensive strain engineering approaches to increase yield, productivity, and robustness of the...
Read More
Improving protein expression in E. coli B‑strains using rapid genome engineering
E. coli B‑strains, such as BL21, and their derivatives are often used for protein expression due to their optimized amino...
Read More
Back To Gallery